To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

COA/ICORS2019: Effects of umbilical cord MSCs, HA and somatotropin in knee osteoarthritis treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2019

COA/ICORS2019: Effects of umbilical cord MSCs, HA and somatotropin in knee osteoarthritis treatment

Vol: 8| Issue: 7| Number:5| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Umbilical Cord Mesenchymal Stem Cells for Treating Early Osteoarthritis of the Knee: A Randomized Controlled Trial

Contributing Authors:
IH Dilogo AMT Lubis J Adiwinata I Liem J Pandelaki AL Hanitya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

28 knees from 15 patients with knee osteoarthritis were randomized to receive an implantation of umbilical cord mesenchymal cell (UC-MSCs) implantation alongside hyaluronic acid injections and somatotropin injections, UC-MSC implantation with hyaluronic acid (HA) injection, or hyaluronic acid injection only. Outcomes of interest included the International Knee Documentation Committee (IKDC) score,...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.